Article info

PDF

Research paper
Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study

Authors

  1. Correspondence to Professor Ryuji Kaji, Department of Neurology, Tokushima University School of Medicine, Tokushima 770-8503, Japan; rkaji{at}tokushima-u.ac.jp
View Full Text

Citation

Kaji R, Imai T, Iwasaki Y, et al
Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study

Publication history

  • Received July 24, 2018
  • Revised November 20, 2018
  • Accepted November 27, 2018
  • First published January 13, 2019.
Online issue publication 
April 09, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.